Provides home-based care throughout the Greater Nashville area and requires independent travel across assigned service areas.
Vanderbilt Health runs a regional health system anchored by Vanderbilt University Medical Center (VUMC) in Nashville, Tennessee. It delivers a broad spectrum of medical services—from primary care to specialized treatments—through hospitals and clinics across Middle Tennessee. The organization blends patient care with academic medicine, translating research into clinical practice and serving as a major training ground for medical professionals. Its competitive advantage comes from its strong research focus and academic affiliation with Vanderbilt University, attracting talent and patients seeking high-quality care. Revenue comes from clinical services, plus research grants and educational programs, with a goal of advancing medical knowledge while improving patient outcomes for the local and broader regional population.
Company Size
10,001+
Company Stage
N/A
Total Funding
N/A
Headquarters
Nashville, Tennessee
Founded
1875
See people who can refer or advise you
Help us improve and share your feedback! Did you find this helpful?
Health Insurance
Dental Insurance
401(k) Retirement Plan
Paid Vacation
Professional Development Budget
Tampa Bay Wave collaborates with Vanderbilt Health to launch dual-region HealthTech|X Accelerator for Behavioral Health and Addiction startups. Collaboration pairs Tampa Bay and Nashville's healthcare ecosystems, giving founders direct access to investors, researchers, clinicians, and licensing opportunities. September 23, 2026 13:58 ET | Source: Tampa Bay Wave TAMPA, Fla., Sept. 23, 2026 (GLOBE NEWSWIRE) - Tampa Bay Wave, a nonprofit, zero-equity startup accelerator, today announced a new partnership with Vanderbilt Health through the Brock Family Center for Applied Innovation to power its 2026 HealthTech|X cohort. The dual-region program will support startups building technology for behavioral health and addiction, two of the fastest-growing and most urgent categories in the industry. Through the partnership, founders selected for the cohort will have direct access to Vanderbilt researchers, clinicians, informaticists and health system leaders, along with paths to clinical research partnerships, technology transfer and licensing of Vanderbilt technologies. "Behavioral health and addiction don't leave room for ideas that only work on paper. Founders need clinicians willing to test their technology against real patients, fast. That's what Vanderbilt brings to this partnership, and paired with everything we've built in Tampa Bay, it gives these founders a shot most Accelerators can't offer," said Linda Olson, Founder and CEO, Tampa Bay Wave. "Vanderbilt Health and the Brock Center for Applied Innovation are excited to collaborate with Tampa Bay Wave to welcome innovative behavioral health and addiction-focused startups into the HealthTech|X cohort. Together, we look forward to connecting founders with Nashville's vibrant healthcare innovation ecosystem and providing exposure to Vanderbilt's world-class clinical, research, and entrepreneurial resources to accelerate their business progress," said Ken Holroyd, MD, MBA, Director of Brock Family Center for Applied Innovation at Vanderbilt Health. "Behavioral health and addiction are two critical areas of healthcare that need innovation from strong founders. The opportunity to pair two of the strongest HealthTech ecosystems in the United States in Tampa and Nashville is unique and a major inflection point for the Tampa Bay Wave, but most importantly provides an opportunity to rally investors, healthcare executives, and more to support the incoming cohort companies in a big way as they grow and scale their startups," said Richard Munassi, MD, MBA, Managing Director, Tampa Bay Wave. "The entire Brock family and Brock Recovery Group team is excited to see the launch of the 2026 HealthTech|X Accelerator program focused on Behavioral Health and Addiction startups. With pairing together a world class Accelerator in the Tampa Bay Wave with all that Nashville and the Brock Family Center for Innovation at Vanderbilt Health has to offer, along with the tremendous ecosystems of Tampa and Nashville, the program will undoubtedly be of high value to all the matriculating startups, now and into the future," said Major Brock, CEO, Brock Recovery Group. The 2026 HealthTech|X cohort will run across both Tampa and Nashville, with in-person session weeks in each city and virtual engagement between them, culminating in pitch nights in each market and a remote Demo Day. Tampa Bay Wave collaborates with a broader ecosystem of healthcare partners, including Tampa General Hospital, BayCare, USF Health, Moffitt Cancer Center and the Tampa Medical Research District. About Tampa Bay Wave Tampa Bay Wave, Inc. is a 501(c)(3) nonprofit providing entrepreneurs with facilitated access to the resources, expertise and capital they need to grow vibrant technology-based companies in Tampa Bay. Since 2013, Tampa Bay Wave has supported more than 670 tech startups that have raised more than $2 billion in capital, created more than 7,600 jobs and completed 34 exits, driving an estimated $450 million in annual economic impact, thanks to grant funding from the U.S. Economic Development Administration (EDA), National Oceanic and Atmospheric Administration (NOAA), and the U.S. Small Business Administration (SBA), plus support from its economic development partners Hillsborough County, Pasco County, and the City of Tampa. Tampa Bay Wave also receives support from individuals, corporations and foundations such as: A-LIGN, Appspace, Bank of America, Celestar, Delta Air Lines/Virgin Atlantic Airlines, Florida High Tech Corridor, Foley & Lardner, Justworks, Kuducom, Nielsen Foundation, NextPath Workforce Solutions, St. Petersburg College, TECO, Thoropass, the University of South Florida and others. In 2026, Tampa Bay Wave was ranked the #3 accelerator in the U.S. and #1 in Florida by TIME. For more information, visit tampabaywave.org. About Vanderbilt Health Vanderbilt Health, a growing academic health system headquartered in Nashville, Tennessee, is one of the largest and most prominent academic systems in the Southeast, providing patient care, conducting research and training the next generation of health professionals. With 43,000 employees, including 4,930 employed clinicians, Vanderbilt Health accommodated more than 3.5 million patient visits last year at its eight hospitals and 180-plus clinic locations. In 2025, Vanderbilt Health contributed $22.13 billion to the regional economy while also providing more than $1 billion in total community benefit and investment including patient financial assistance, medical research, health professional education, community grants and unreimbursed costs for government health programs. For more information, visit VanderbiltHealth.com.
Yale's jasmiry Bennett named Vice President and Chief Advanced Practice Officer for Vanderbilt Health. Jasmiry (Jas) Bennett, DNP, MBA, APRN, ACNP-BC, has been named the inaugural Vice President and Chief Advanced Practice Officer for Vanderbilt Health, according to an announcement Aug. 12 from System Chief Nursing Officer Karen Keady, PhD, RN, NEA-BC. Bennett, currently Advanced Practice Director at Yale New Haven Hospital, will begin her new role in November. "Dr. Bennett is a highly respected health care leader with more than 20 years of progressive experience in clinical practice, operations and executive leadership," Keady said. "Throughout her career, she has demonstrated a strong commitment to advancing the role of advanced practice providers, building high-performing teams, fostering interdisciplinary collaboration, and creating opportunities for APPs to practice at the top of their licensure." In her current role at Yale New Haven Hospital, Bennett provides strategic leadership across multiple clinical service lines and leads initiatives focused on quality, patient access, workforce development, operational excellence, and care delivery. She previously held leadership roles at Baylor Scott & White Health and Hackensack University Medical Center, where she helped establish and expand APP programs, strengthen governance structures, and drive innovative approaches to patient care and provider engagement. As Vanderbilt Health's first Vice President and Chief Advanced Practice Officer, Bennett will provide strategic leadership for the APP community across the enterprise and help shape the future of advanced practice. "Her ability to build strong relationships, lead transformational change, and align clinical and operational priorities will be invaluable as Vanderbilt Health continues to advance its mission of personalizing the patient experience through quality, innovation and discovery," Keady said. In the new role, Bennett will report directly to Keady, with a matrixed reporting relationship to Chief Medical Officer and Senior Vice President for Clinical Affairs Rick Wright, MD, and Chief of Staff for Corporate Clinical Affairs Cecelia Theobald, MD, MPH. "Dr. Bennett brings to Vanderbilt a wealth of experience leading advanced practice teams across multiple academic medical centers," Theobald said. "We are looking forward to how she will further enhance our already strong Vanderbilt Health culture and encourage us to continue to further develop these professions." "I look forward to the progress she will help us achieve in organizing our APP structure," Wright said.
Tennessee Fertility Institute announces patient services alliance with Vanderbilt Health. FinanceWire Aug. 20, 2026, 05:07 PM Nashville, TN, August 20th, 2026, FinanceWire Alliance expands access to comprehensive reproductive healthcare services for fertility patients throughout Tennessee Tennessee Fertility Institute (TFI), a leading provider of comprehensive fertility care, today announced a new patient services alliance with the Vanderbilt Health Fertility Clinic (VH) designed to support patients throughout their fertility treatment journey while leveraging the specialized expertise and resources of both organizations. Through the alliance, VH's reproductive endocrinologist Ryan Heitmann, D.O., will perform egg retrievals and embryo transfers at TFI. VH will continue to oversee patient care coordination and cycle monitoring, while TFI will provide the laboratory, embryology, cryopreservation, operating room and financial services associated with treatment. The alliance brings together VH's clinical care and patient management with TFI's advanced fertility infrastructure and laboratory services, providing patients with coordinated access to the resources needed throughout an IVF cycle. "Demand for high-quality fertility care continues to grow, and this alliance allows us to expand access while bringing together the strengths of two highly respected fertility programs," said Christopher Montville, M.D., Partner and Medical Director at TFI. "By combining Vanderbilt Health's clinical expertise with TFI's advanced laboratory and treatment capabilities, we can help more patients access the comprehensive care they need to build their families." TFI is part of The Prelude Network(R)(Prelude), the largest network of fertility clinics in North America. Its team of innovative and empathetic reproductive endocrinologists spend real time with each family to understand their goals and develop personalized treatment plans. "Our priority is ensuring patients receive exceptional, seamless care throughout every stage of their fertility journey," said Dr. Heitmann. "Working with TFI gives our patients access to advanced laboratory and treatment resources that meet rigorous quality and safety standards, while allowing our team to remain closely involved in their care from cycle planning and monitoring through treatment." Prelude is the clinical network of Inception Fertility(TM)(Inception), a family of fertility brands and the largest provider of fertility services in North America, and its physicians include innovators in fertility care who have pioneered some of today's most advanced reproductive technologies, including vitrification, fertility preservation, and preimplantation genetic testing (PGT). About Tennessee Fertility Institute Tennessee Fertility Institute (TFI) specializes in the treatment of male and female infertility, as well as LGBTQ+ and single parent fertility. The clinic offers comprehensive fertility assessment and testing services, and its full range of comprehensive fertility services include in vitro fertilization (IVF, intrauterine insemination (IUI), fertility preservation (including egg freezing, sperm freezing, and oncofertility), third-party reproduction and more. About The Prelude Network(R) The Prelude Network(R)(Prelude), the fastest-growing network of fertility clinics and largest provider of comprehensive fertility services in North America, is the clinic network of Inception Fertility(TM)- a family of fertility brands that touches every part of the fertility journey, including diagnostics and treatment to financial accessibility. Each clinic, as part of Prelude, is committed to delivering the highest level of personalized fertility care by the nation's leading reproductive endocrinologists, embryologists and practitioners by focusing on an excellence in science, medicine and the patient experience. The growing Prelude Network has more than 90 total locations nationwide, offering a wide range of fertility services including egg freezing, IVF, genetic testing, LGBTQ+ fertility options, and egg/embryo storage, among others. Those clinics within Prelude include Aspire Fertility Austin (Texas); Aspire Fertility Dallas (Texas); Aspire Fertility San Antonio (Texas); Aspire Fertility Houston (Texas); Advanced Fertility Center of Chicago (Illinois); Center for Reproductive Medicine (Florida); Indiana Fertility Institute (Indiana); IVFMD (Florida); Main Line Fertility (Pennsylvania); NYU Langone Fertility Center (New York); NYU Langone RSNY (New York); Pacific Centre for Reproductive Medicine (Canada); Pacific Fertility Center (California); Regional Fertility Program (Canada); Reproductive Biology Associates (Georgia); Reproductive Science Center of New Jersey (New Jersey); Tennessee Fertility Institute (Tennessee), and The Reproductive Medicine Group (Florida). About Inception Fertility(TM) Inception Fertility(TM)(Inception) is a family of fertility brands committed to helping patients build their own families. Built by patients for patients, Inception's purpose is to achieve the highest bar in experience, science and medicine in an effort to enhance each patient's experience and achieve better outcomes. Inception's medical experts are leading pioneers in fertility care. Its doctors are some of the first to use breakthrough assisted reproductive technologies (ART) - including in vitro fertilization (IVF), preimplantation genetic testing (PGT) and fertility preservation services - and they continue to lead the industry by building on these technologies by through development, research and thought leadership. Through its growing family of national organizations - which includes The Prelude Network(R), the fastest-growing network of fertility clinics and largest provider of comprehensive fertility services in North America; MyEggBank(R), one of the largest frozen donor egg banks in North America; BUNDL Fertility(TM), a multi-cycle fertility service bundling program; HavenCryo(TM), a long-term reproductive preservation and storage solution provider and NutraBloom(R), a premium lifestyle brand with expertly formulated supplements to support individuals' health and wellness goals for preconception - Inception is working to deliver on its promise to push the envelope of what is possible for exceeding patient expectations. Media Contact Mia Humphreys [email protected] +1 239-297-6592 Contact. Media Contact Mia Humphreys Tennessee Fertility Institute [email protected] Sponsored Financial Content
Vanderbilt's AI initiative aims to reduce wait times for Alzheimer's patients. Vanderbilt Health, supported by a grant from Eli Lilly, is developing an AI-powered tool within their EHR system to expedite Alzheimer's treatment, focusing on reducing delays in monoclonal antibody therapy. Aug. 6, 2026 Vanderbilt Health has put together a project to accelerate the process of getting patients to Alzheimer's treatment, thanks to a grant from Eli Lilly and Company. The project is detailed in a news article by Paul Govern. Through the 18-month, $600,000 initiative, the team will develop an artificial intelligence (AI) tool inside their electronic health record system (EHR). The device will help reduce the time that patients wait to receive monoclonal antibody therapy after their healthcare provider refers them. Amalia Peterson, MD, Assistant Professor of Neurology and a co-principal investigator on the project told Govern that the AI agent will not replace clinical judgement. Instead, "it will remove a lot of the friction that keeps patients waiting." The agent will work by summarizing a patient's relevant chart information once they are recommended by a clinician for cognitive concern, and reporting gaps that might slow evaluation. It will also "recommend whether a case should be routed as priority or standard," however, "clinicians will retain the ability to accept, edit or override every recommendation." The team is considering developing additional AI agents within the EHR to streamline other areas of Alzheimer's care, but will first focus on helping patients receive their first monoclonal antibody infusion sooner. Managing Editor. Erin Brady is Managing Editor of Medical Laboratory Observer. The new frontier of point-of-care testing. Discover how next-generation handheld diagnostics are changing medicine at the speed of care. Get the Free eBook
Vanderbilt Health, Siemens Healthineers sign $87 million technology partnership. DOTmed July 28, 2026 Gus Iversen Vanderbilt Health has entered a multiyear, $87 million Value Partnership with Siemens Healthineers to upgrade diagnostic imaging and radiation oncology technology across its Nashville-area hospitals. The agreement covers equipment modernization, technology standardization, service operations and workforce development programs. According to the organizations, the partnership also establishes a framework for technology planning, installation support and operational performance initiatives aligned with Vanderbilt Health's clinical and operational priorities. The Nashville, Tennessee-based health system said the agreement is designed to streamline future purchases and upgrades of imaging and radiation oncology equipment while supporting broader operational initiatives. Under the partnership, Siemens Healthineers, based in Malvern, Pennsylvania, will supply technology for magnetic resonance imaging, computed tomography, molecular imaging, interventional radiology and radiation oncology. The systems will...